| Literature DB >> 26823361 |
Francisco Abecasis1, Inês Marques2, Celeste Bento3, Anabela Ferrão4.
Abstract
Screening for critical congenital heart defects in newborn babies can aid in early recognition, with the prospect of improved outcome. However, as this universal newborn screening is implemented, there will be an increasing number of false-positive results. In order to avoid multiple investigations and uncertainty, an haemoglobin (Hb) variant must be included in the differential diagnosis in otherwise well newborns with low oxygen saturation by pulse oximetry. We describe a novel fetal Hb variant (heterozygous γ-globin gene (HBG1) mutation in exon 2 c.202G>A (p.Val68Met)) identified in a newborn with positive pulse oximetry screening for congenital heart disease. 2016 BMJ Publishing Group Ltd.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26823361 PMCID: PMC4735275 DOI: 10.1136/bcr-2015-213615
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X